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Limited data identify the risk factors for infection with
Enterobacteriaceae resistant to third-generation cepha-
losporins among residents of long-term-care facilities.
Using a nested case-control study design, nursing home
residents with clinical isolates of Enterobacteriaceae resist-
ant to third-generation cephalosporins were compared to
residents with isolates of Enterobacteriaceae susceptible to
third-generation cephalosporins. Data were collected on
antimicrobial drug exposure 10 weeks before detection of
the isolates, facility-level demographics, hygiene facilities,
and staffing levels. Logistic regression models were built to
adjust for confounding variables. Twenty-seven case-resi-
dents were identified and compared to 85 controls.
Exposure to any cephalosporin (adjusted odds ratio [OR]
4.0, 95% confidence interval [CI] 1.2 to13.6) and log per-
centage of residents using gastrostomy tubes within the
nursing home (adjusted OR 3.9, 95% CI 1.3 to 12.0) were
associated with having a clinical isolate resistant to third-
generation cephalosporins.
A
ntimicrobial drug resistance is a concern in nursing
homes, facilities where most residents are elderly,
frail, and on multiple medications. Gram-negative bacteria
resistant to third-generation cephalosporins have emerged
as a challenge both in the acute and long-term-care setting
(1–9). These organisms, such as those that produce extend-
ed-spectrum β-lactamase (ESBL) or contain the AmpC β-
lactamase, can spread rapidly, especially in close living
quarters (1,2).
Identifying modifiable risk factors for acquiring these
organisms, such as antimicrobial drug use, can clarify
strategies to reduce spread (1,2). Little is known about
whether prior exposure to antimicrobial drugs is a risk fac-
tor for Enterobacteriaceae resistant to third-generation
cephalosporins in the long-term care setting. Wiener et al.
reported that prior exposure to ciprofloxacin or trimetho-
prim-sulfamethoxazole was an independent predictor of
colonization with Escherichia coli resistant to ceftazidime
among nursing home residents (2). Molecular analysis of
isolates showed that a particular resistance-conferring
plasmid appeared frequently, which supports the growing
concern that long-term facilities may act as a reservoir for
antimicrobial drug–resistant organisms. We previously
conducted a prospective, cohort study that examined risk
factors for antimicrobial drug resistance in 50 nursing
homes in Canada and the United States (10). Using these
data, we performed a nested case-control analysis to assess
whether prior exposure to antimicrobial drugs was a risk
factor for infection with Enterobacteriaceae that are resist-
ant to third-generation cephalosporins. Staffing character-
istics, facilities for hand hygiene, and nursing home
resident characteristics were examined as potential risk
factors as well. 
Materials and Methods
Study Design
The methods of the original study from which these
data were acquired have been previously published (10).
Briefly, 50 nursing homes with >100 beds in four
provinces (Ontario, Manitoba, Alberta, Saskatchewan) and
four states (Minnesota, Michigan, North Dakota, Montana)
were enrolled in the study. During a 12-month period, res-
idents treated with systemic antimicrobial drugs were
identified, and antimicrobial prescriptions were recorded,
including name, dose, and duration. Infection control prac-
titioners from each facility recorded the name and antimi-
crobial-susceptibility patterns of all clinical bacterial
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Susceptibility testing was performed by using methods
recommended by the National Committee for Clinical
Laboratory Standards (NCCLS). Complete information on
all clinical bacterial cultures sent for testing from each
home was obtained. These clinical isolates were obtained
for diagnostic purposes among residents in the nursing
homes. To minimize biased sampling, only cultures sent
for signs of suspected clinical infection were included.
None of the homes at the time of study collected bacterial
specimens from residents for surveillance purposes only.
Enterobacteriaceae were identified by conventional meth-
ods. A survey was performed before the study to ensure
that laboratories adhered to NCCLS methods.  Infection
control practitioners from each facility recorded the name
and antimicrobial-susceptibility patterns of all clinical bac-
terial cultures obtained from study residents. Data record-
ed for each nursing home included the following: number
of resident beds; staffing levels (registered and nonregis-
tered nursing staff hours, healthcare aide hours, infection
control practitioner hours, physicians hours, and access to
an infectious disease specialist); infrastructure for hygiene
facilities (number of showers and tubs per facility and
sinks per 100 resident beds); percentage of residents with
intravenous catheters, urinary catheters, and gastrostomy
tubes; percentage of residents that were either wheelchair
or bed bound; and information on recent acute-care stay
(new admissions and returns).
Case Definition
The study population was drawn from the fixed cohort
of nursing home residents used in the original study. Only
those residents with clinical isolates of Enterobacteriaceae
resistant or susceptible to third-generation cephalosporins
were eligible to be case-residents and controls in this
analysis. Case-residents were defined as nursing home res-
idents in whom a clinical Enterobacteriaceae isolate
resistant to third-generation cephalosporins was detected.
For each case-resident, we randomly selected three con-
trol-residents from those residents in whom clinical iso-
lates of Enterobacteriaceae sensitive to third-generation
cephalosporins were obtained. Since repeat isolates may
not represent independent events, we assessed only the
first clinical isolate obtained from each resident (case-
residents and control-residents).
Data were collected at the individual-resident level
regarding prior antimicrobial drug use and antimicrobial
drug resistance and susceptibility of bacterial isolates.
Total antimicrobial drug use, use of any cephalosporins,
use of third-generation cephalosporins, use of fluoro-
quinolone, and use of trimethoprim-sulfamethoxazole
were recorded. Covariates were defined as those variables
collected at the level of the nursing home, including
staffing and patient and facility characteristics.
Statistical Analysis
We sought to compare antimicrobial drug exposures in
nursing home residents from whom Enterobacteriaceae
resistant to third-generation cephalosporins were isolated
to antimicrobial drug exposures in nursing home residents
from whom susceptible Enterobacteriaceae cultures were
obtained. Antimicrobial exposures and nursing home
covariates were examined as possible predictors. Log
transformations were used when distributions of variables
were skewed. All possible predictors were tested for
collinearity. Antimicrobial drug exposure was measured
in the 10 weeks before resistant bacteria were detected in
residents and was compared to antimicrobial drug expo-
sure during a 10-week interval in residents with suscepti-
ble organisms. In the absence of any evidence defining an
optimal period for assessment of antimicrobial drug expo-
sures, 10 weeks was selected by consensus opinion of five
infectious disease specialists with research expertise in
the field of antimicrobial drug resistance. All antimicro-
bial exposures were considered as binary. This strategy
was used because all microbial variables, despite log
transformation, were highly skewed. Odds ratios were
calculated, representing the risk of nursing home residents
having antimicrobial drug–resistant clinical isolates com-
pared to antimicrobial drug–susceptible organisms. To
assess for the possible effect of clustering for facility-
level variables, univariate analyses were also performed
with logistic regression with random factors (logistic-
binomial model) (Egret 2.031, Cytel Software Corp.,
Cambridge, MA) and compared with a logistic regression
model in which the factors are fixed (SPSS 10.0, SPSS
Inc., Chicago, IL). Amultivariable model was constructed
in which variables with a p value <0.25 and variables rep-
resenting the various antimicrobial drugs were selected
for inclusion, and the final multivariable model was con-
structed by using a backwards, stepwise approach. All
data entry was performed with SAS version 6.0 and 7.0
(SAS Institute, Cary, NC). Analysis was performed by
using SPSS 10.0 and Egret 2.031. The Hosmer and
Lemeshow test was performed to evaluate the overall fit
of the model (11). Ethics approval for this study was
obtained through McMaster University’s ethics review
board. 
Results
Twenty-nine case-residents were identified, and 87
control-residents were initially selected from 26 nursing
homes. Because of organizational changes in one nursing
home during the course of the study, no covariate data
could be obtained. Since such group-level data could not
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home were dropped from the analysis. This included two
case-residents and two control-residents. Ignoring the
missing group-level variables and including these resi-
dents in the analysis on the basis of their individual-level
variables made no difference in the estimates subsequent-
ly reported (data not shown). The distribution of types of
Enterobacteriaceae among case-residents and control-res-
idents is shown in Table 1. A greater proportion of
Citrobacter and Enterobacter species were identified in
samples from case-residents compared to samples from
control-residents (p = 0.01 for each), and a greater propor-
tion of E. coli isolates were identified in samples from con-
trol-residents compared to samples from case-residents
(p = 0.01). Most clinical specimens were isolated from
urine samples, and a greater proportion of urine isolates
were detected in specimens from control-residents as com-
pared to case-residents (p = 0.05) (Table 2).
Univariate analyses of individual-level exposures and
facility-level exposures are shown in Tables 3 and 4. The
following variables were considered in the multivariable
model: prior exposure to any antimicrobial drug, to a
cephalosporin, to a third-generation cephalosporin, to a
fluoroquinolone, or to trimethoprim-sulfamethoxazole; the
log number of primary care physician hours per 100 resi-
dent beds; whether an infectious disease physician was on
staff; the number of new admissions from acute care hos-
pitals within the last year per 100 resident beds; and the
log percentage of residents in the nursing home with a
gastrostomy tube.
The only variables that remained significant after mul-
tivariable modeling were prior use of any cephalosporin
(odds ratio [OR] 4.0, 95% confidence interval [CI] 1.2 to
13.6, p = 0.029), and log percentage of residents with a
gastrostomy tube (OR 3.9, 95% CI 1.3 to 12.0, p = 0.016).
The p value obtained for the Hosmer and Lemeshow test
was 0.138, which suggests that the overall fit of this model
is reasonable.
Discussion
Enterobacteriaceae infections resistant to cephalo-
sporins are of concern in long-term care facilities and in
the acute-care setting (1–9). Patients with infections resist-
ant to third-generation cephalosporins have been reported
to have had longer hospital stays, higher death rates, and
greater hospital costs than patients whose infections are
susceptible to third-generation cephalosporins (4). A sur-
vey of infection control practitioners in Ontario showed
that no standard approach exists to dealing with ESBL-
producing E. coli and Klebsiella spp. in long-term-care
facilities (12). Reservoirs of resistant Enterobacteriaceae
species will continue to emerge in this setting despite
implementation of control measures.
Our findings show that recent exposure to any
cephalosporin is associated with the isolation of third-gen-
eration cephalosporin–resistant Enterobacteriaceae in
nursing home residents. Knowledge of previous exposure
may help physicians anticipate this particular pattern of
resistance.
Few studies have assessed risk factors for
Enterobacteriaceae resistance to cephalosporins in long-
term-care facilities. Weiner et al. described an outbreak of
ceftazidime-resistant E. coli infections in Chicago nursing
homes (2). Those researchers conducted a case-control
study and found that ciprofloxacin or trimethoprim-sul-
famethoxazole exposure was associated with ceftazidime-
resistant E. coli in nursing home residents. Cephalosporin
treatment may have been given after fluoroquinolone
resistance was detected, and this treatment may be linked
to cephalosporin resistance found in their study. Muder et
al. evaluated modifiable risk factors for antimicrobial
drug–resistant  Enterobacteriaceae infection among
patients from a long-term Veterans Affairs facility in
Pittsburgh (13). In this case-control study, patient debility,
age, coexisting conditions, and prior antimicrobial therapy
were examined as risk factors associated with multidrug-
resistant  Enterobacteriaceae infections. Case-patients
were identified as having an Enterobacteriaceae infection
resistant to two of the following groups of antimicrobial
drugs: piperacillin, third-generation cephalosporins, or
gentamicin. Only a pressure ulcer [OR 12.2, 95% CI 3.3 to
44.2] and prior ampicillin therapy [OR 13.7, 95% CI 2.2 to
84.0] were associated with resistant Enterobacteriaceae
infection. In contrast, we did not assess individual-level
covariates. No association was found between prior
cephalosporin therapy and a multiple-resistant infection,
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Table 1. Distribution of Enterobacteriaceae organisms isolated 
from case-patients and controls 
Genus  Case-patients (%)  Controls (%) 
Proteus spp.  7 (26)  17 (20) 
Citrobacter spp.  6 (22)  4 (5) 
Enterobacter spp.  5 (18)  2 (2) 
Escherichia coli  4 (15)  47 (55) 
Klebsiella spp.  3 (11)  11 (13) 
Morganella spp.  1 (4)  4 (5) 
Serratia marcescens  1 (4)  0 (0) 
Total  27  85 
Table 2. Distribution of sites from which Enterobacteriaceae were 
isolated 
Site  Case-patients (%)  Controls (%) 
Urine  20 (74)  77 (91) 
Wound  3 (11)  2 (2) 
Eye  3 (11)  2 (2) 
Skin  1 (4)  3 (4) 
Sputum  0 (0)  1 (1) 
Total  27  85 but whether prior cephalosporin therapy and the acquisi-
tion of cephalosporin-resistant infections are linked is
unknown. A similar study performed previously by this
group identified exposure to ciprofloxacin as a risk factor
for the acquisition of ciprofloxacin-resistant gram-nega-
tive bacteria (14). Our findings confirm that patient debil-
ity and prior antimicrobial drug therapy are associated with
acquisition of resistant bacteria. 
In the acute-care setting, similar risk factors for the
acquisition of broad-spectrum cephalosporin-resistant
Enterobacteriaceae have been recognized (15–19). The
risk of acquiring multidrug-resistant bacterial infection has
been reported as increasing in hospitalized patients with
prior third-generation cephalosporin therapy (6,18,19). A
hospital-based case-control study performed in Argentina
examined risk factors for ceftazidime-resistant K. pneumo-
niae. Prior antimicrobial drug use was associated with
acquisition of this type of resistant infection [adjusted OR
6.21, 95% CI 1.20 to 32.01]. Other risk factors found were
prior use of ciprofloxacin, nosocomial infection, and hos-
pitalization stay >6 days (15). Bisson et al. also looked at
risk factors for acquisition of ESBL-producing Klebsiella
spp. and E. coli in which patients with this resistance pat-
tern were compared to patients with no culture exhibiting
this resistance pattern (16). Only length of hospitalization
stay was associated with colonization with ESBL-produc-
ing E. coli and Klebsiella spp. [adjusted OR 1.11, 95% CI,
1.02 to 1.21]. Prior receipt of antimicrobial therapy was
not associated with colonization in these patients, but none
were exposed to third-generation cephalosporins. Since
our study was set in long-term-care facilities and because
individual measurements were not done, length of stay was
not assessed. Lin et al. performed a case-control study
evaluating risk factors for ESBL-producing K. pneumoni-
ae among hospital patients in Taiwan (17). Prior use of cef-
tazidime was found to be associated with ESBL-producing
K. pneumoniae infection compared to non–ESBL-produc-
ing  K. pneumoniae infection. A case-control study by
Bonomo et al. did not find an association between fecal
colonization of cefotaxime-resistant gram-negative bacilli
and antimicrobial drug use 4 weeks before admission to
the hospital (20).
Comparison of antimicrobial drug-sensitive organisms to
antimicrobial drug-resistant organisms cannot infer absolute
risk for exposure to that antimicrobial drug (21,22).
However, Lipsitch has discussed several advantages of cal-
culating conditional OR (ORc) versus simple OR (ORs)
when interpreting associations between antimicrobial drug
Nursing Home Residents and Enterobacteriaceae
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 6, June 2004 1053
Table 3. Univariate logistic regression analyses of individual-level variables with clinical isolate of Enterobacteriaceae resistant to third-
generation cephalosporins as the dependent variable 
Variables
a  Case-patients (%)  Controls (%)  OR (95% CI)
b  p value 
Any antimicrobial drug  13 (48)  27 (32)  2.0 (0.8 to 4.8)  0.125 
Any cephalosporin  8 (30)  6 (7)  5.5 (0.1 to 0.6)  0.004 
Third-generation cephalosporin  2 (7)  2 (2)  3.3 (0.04 to 2.2)  0.242 
Fluoroquinolone  3 (11)  7 (8)  1.4 (0.1 to 3.0)  0.649 
Trimethoprim/sulfamethoxazole  4 (15)  5 (6)  2.8 (0.1 to 1.4)  0.150 
a10 weeks before date of confirmed Enterobacteriaceae infection. 
bOR, odds ratio; CI, confidence interval. 
Table 4. Univariate logistic regression analyses of nursing home–level variables with clinical isolate of Enterobacteriaceae resistant to 
third-generation cephalosporins as the dependent variable
a 
Variables  OR (95% CI)  p value 
>200 beds (no.)  0.85 (0.35 to 2.05)  0.718 
Nursing units per 100 beds (log no.)   4.09 (0.25 to 66.45)  0.322 
RN FTE h (log no.)  1.21 (0.18 to 8.31)  0.846 
NA FTE h (log no.)  1.91 (0.44 to 8.43)  0.391 
Healthcare aide FTE h (log no.)  0.99 (0.95 to 1.02)  0.356 
ICP FTE h (log no.)  0.91 (0.19 to 4.43)  0.910 
Primary care physician FTE h (log no.)  0.28 (0.08 to 0.91)  0.034 
Infectious disease specialist on staff  0.40 (0.16 to 1.03)  0.057 
Tubs/showers per 100 beds/facility (log no.)  2.25 (0.48 to 10.48)  0.303 
Sinks per 100 beds (no.)   1.00 (0.99 to 1.01)  0.965 
New admissions from to acute care prior y/100 beds (no.)  1.00 (0.99 to 1.01)  0.205 
Residents readmitted acute care hospitals prior y/100 beds (no.)  1.01 (0.99 to 1.03)  0.481 
Residents with urinary catheter (%)  1.01 (0.90 to 1.13)  0.923 
Residents with intravenous catheter (%)  1.64 (0.68 to 3.9)  0.272 
Residents with gastrostomy tube (log %)  5.02 (1.72 to 14.70)  0.003 
>50% residents unable to ambulate (no.)  1.34 (0.54 to 3.31)  0.533 
aOR, odds ratio; CI, confidence interval; FTE, full -time equivalent; RN, registered nurse; NA, nursing aide; ICP, infection control practitioner.  use and resistant organisms (23). ORs determines a patient’s
individual risk of acquiring a resistant infection after receiv-
ing treatment compared to not getting an infection after
receiving treatment. ORc determines the risk of a resistant
infection compared to the risk of a nonresistant infection,
which allows for insight into whether a suspect infection in
a patient is more likely to be resistant to a particular antimi-
crobial drug compared to someone who has not been treat-
ed (23). Widespread treatment with antimicrobial drugs
promotes the eradication of antimicrobial-susceptible organ-
isms but also confers a selective advantage for developing
antimicrobial-resistant organisms. Measuring ORcmay even
be more useful for clinicians than knowing the absolute risk
because it gives information about the community-level risk
of having a resistant organism compared to a susceptible
organism in persons with a particular recent antimicrobial
drug history (23). Making this comparison is useful for cli-
nicians who are evaluating the odds of a patient’s being
infected with a resistant organism.
In addition to antimicrobial drug exposure, the percent-
age of residents with gastrostomy tubes in the home was
also found to predict Enterobacteriaceae infection resist-
ant to third-generation cephalosporins. In this analysis,
percentage of gastrostomy tubes among home residents
served as a proxy for generalized debility within each nurs-
ing home, and our findings suggest that more debilitated
patients may be more predisposed to acquiring resistant
organisms. Debilitated patients are most likely to harbor
resistant organisms (24). Since we do not know the strain
of resistant bacteria applicable to each patient, we cannot
infer with certainty that a gastrostomy tube in a nursing
home resident is a risk factor for this type of resistant
infection. However, Weiner et al. identified gastrostomy
tube use at the patient-level as a risk factor for acquiring
resistant Enterobacteriaceae (2). Infections directly asso-
ciated with gastrostomy tube contamination, resulting in
antimicrobial treatment or hospitalization (25,26), have
also been reported,. However, since gastrostomy tube sites
were not systematically tested in this study, this finding
cannot be inferred. 
Strengths of this study are that residents were drawn
from a large number of nursing homes in both Canada and
the United States, exposures at both the individual and
aggregate levels were examined, and a wide range of vari-
ables were considered, including staffing and infrastruc-
ture for hand hygiene. Our study has some limitations,
including the following: the date of actual acquisition of
resistant bacteria is not known; we only examined clinical
isolates, obtained for diagnostic purposes, which may have
led to a sampling bias; and individual level coexisting con-
ditions were not measured. Given the large size of the orig-
inal study, measuring coexisting conditions was not
feasible. Another limitation is that facilities with higher
levels of resistant bacteria among residents may obtain
more clinical specimens (or vice versa), which may have
led to bias in the sample used. Cross-infection within a
facility could not be assessed because of lack of molecular
typing of isolates. Admissions and readmissions to acute-
care facilities within the last year were not identified as
risk factors for infection with Enterobacteriaceae resistant
to third-generation cephalosporins. The 12-month period
may have been too long, but a significant association may
have been identified with a 3-month period. In conclusion,
prior exposure to cephalosporins and an increased use of
gastrostomy tubes among nursing home residents predicts
for infection with Enterobacteriaceae resistance to third-
generation cephalosporins. 
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